InvestorsHub Logo
Followers 59
Posts 7367
Boards Moderated 0
Alias Born 10/20/2014

Re: Biobillionair post# 119042

Thursday, 12/14/2017 8:01:00 AM

Thursday, December 14, 2017 8:01:00 AM

Post# of 423817
BB-I appreciate all of your updates and insights that you post on this board. AMRN is setting itself up for R-I results which if positive will
have to get out two messages to the public:

1. That Vascepa is a safe and effective medication to reduce the risks of
CVD.

2. That DS are not effective and may even be more damaging due to oxidation
and contanimants such as mercury.

On a side note I think the FDA messed up bigtime with its message regarding
Triglyceride levels. As certain as you may be that the FDA did AMRN (not
to mention those with high tryglyceride levels) wrong with its treatment
of AMRN, it remains to be seen exactly how FDA will clean up the mess.

Ultimately, the most valuable asset AMRN may have will be its patent portfolio which should be wielded as a weapon.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News